Centaur Pharmaceuticals, Inc. - X.CTP- Profile

Centaur Pharmaceuticals, Inc.. The Company develops small molecule pharmaceutical compounds for the treatment of diseases which involves the interruption and susequent restoration of blood supply. The Company's initial therapeutics targets are neurogenerative conditions such as Parkison's disease, AIDS dementia and Alzheimer's disease. The Company's programs targets diseases that affects the brain such as acute cerebral stroke and dementia. The Company is conducting preclinical programs to develop therapeutics for the treatment of arthritis and myocardial ischema. Develops small molecule pharmaceutical compounds for the treatment of diseases which involves oxidative stress